← Back to Search

Anti-infective

Treatment for Pink Eye (SCH1TAIC Trial)

Phase 2
Waitlist Available
Led By David Ritterband, MD
Research Sponsored by Sacsh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 5
Awards & highlights

SCH1TAIC Trial Summary

The objective of this study is to evaluate the efficacy of Sasch1, a novel anti-infective eyedrop, in the treatment of acute infectious conjunctivitis.

Eligible Conditions
  • Pink Eye

SCH1TAIC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 5
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 5 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Clinical Resolution Among Who Received SCH1 or Placebo on Day 5

SCH1TAIC Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TreatmentExperimental Treatment1 Intervention
Active treatment with SCH-1
Group II: PlaceboPlacebo Group1 Intervention
Vehicle minus active components
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SCH-1
2021
Completed Phase 2
~30

Find a Location

Who is running the clinical trial?

SacshLead Sponsor
David Ritterband, MDPrincipal InvestigatorSacsh
1 Previous Clinical Trials
500 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Jacqueline Dauhajre, MD
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis
2021. "The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05356793.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top